{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:50:45Z","timestamp":1789019445289,"version":"build-2803163510"},"reference-count":45,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"3","license":[{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>Introducci\u00f3n. Las tasas de \u00e9xito del tratamiento de la tuberculosis contin\u00faan siendo sub\u00f3ptimas.Objetivo. Identificar los factores asociados al tratamiento no exitoso para tuberculosis en pacientes con antecedentes de tratamiento para la tuberculosis.Materiales y m\u00e9todos. Se realiz\u00f3 un estudio observacional retrospectivo, anal\u00edtico, de cohorte de pacientes que reingresaron a un programa de micobacterias en Cali, Colombia. Se incluyeron mayores de 15 a\u00f1os con tuberculosis pulmonar entre el 2015 y el 2019 con antecedentes de tratamiento para la tuberculosis. Se excluyeron los pacientes con tuberculosis resistente.Resultados. Ingresaron 605 pacientes con antecedentes de tratamiento, 60 % por tratamiento inconcluso y 40 % por reca\u00edda. En comparaci\u00f3n con los pacientes que reingresaron por reca\u00edda (ORa= 2,34; IC=1,62-3,38), las variables que explicaron de manera independiente el no tener \u00e9xito con el tratamiento para la tuberculosis al egreso fueron: estar en situaci\u00f3n de calle (ORa = 2,45; IC = 1,54-3,89), ser farmacodependiente (ORa = 1,95; IC=1,24-3,05), tener coinfecci\u00f3n tuberculosis\/VIH (ORa = 1,69; IC =1,00-2,86) o diabetes (ORa =1,89; IC=1,29-2,77), y el incumplimiento de un tratamiento previo por p\u00e9rdida de seguimiento, abandono u otras causas. Las variables program\u00e1ticas que favorecieron el \u00e9xito del tratamiento fueron la asesor\u00eda de la prueba voluntaria de VIH (p &lt;0,001) y la realizaci\u00f3n de la prueba de VIH (p &lt; 0,001).Conclusi\u00f3n. Estar en situaci\u00f3n de calle, ser farmacodependiente, tener coinfecci\u00f3n de tuberculosis y VIH, o diabetes, as\u00ed como el incumplimiento del tratamiento previo por p\u00e9rdida del seguimiento, abandono o fracaso del mismo, dificultaron el \u00e9xito del tratamiento antituberculoso. En la primera atenci\u00f3n al reingreso de los pacientes con tuberculosis se deben identificar y abordar estas caracter\u00edsticas.<\/jats:p>","DOI":"10.7705\/biomedica.6961","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T16:31:03Z","timestamp":1697819463000},"page":"360-373","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":6,"title":["Factores asociados al tratamiento no exitoso para tuberculosis en pacientes previamente tratados en Cali, Colombia, en el periodo 2015-2019","Factors associated with unsuccessful treatment outcome for tuberculosis in previously treated patients in Cali, Colombia, during the period 2015-2019"],"prefix":"10.7705","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3171-1249","authenticated-orcid":false,"given":"Liddy","family":"Varela","sequence":"first","affiliation":[{"name":"Grupo Interdisciplinario de Investigaci\u00f3n en Epidemiolog\u00eda y Salud P\u00fablica, Universidad Libre, Cali, Colombia"},{"name":"Grupo Interdisciplinario de Investigaci\u00f3n en Epidemiolog\u00eda y Salud P\u00fablica, Universidad Libre, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4166-9267","authenticated-orcid":false,"given":"Jimena","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Grupo Interdisciplinario de Investigaci\u00f3n en Epidemiolog\u00eda y Salud P\u00fablica, Universidad Libre, Cali, Colombia"},{"name":"Grupo Interdisciplinario de Investigaci\u00f3n en Epidemiolog\u00eda y Salud P\u00fablica, Universidad Libre, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9749-3598","authenticated-orcid":false,"given":"Pamela K.","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"rupo de Investigaci\u00f3n de Microbiolog\u00eda, Industria y Medio Ambiente, Universidad Santiago de Cali, Cali, Colombia"},{"name":"rupo de Investigaci\u00f3n de Microbiolog\u00eda, Industria y Medio Ambiente, Universidad Santiago de Cali, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2231-4591","authenticated-orcid":false,"given":"Lucy","family":"Luna","sequence":"additional","affiliation":[{"name":"Grupo Interdisciplinario de Investigaci\u00f3n en Epidemiolog\u00eda y Salud P\u00fablica, Universidad Libre, Cali, Colombia"},{"name":"Grupo Interdisciplinario de Investigaci\u00f3n en Epidemiolog\u00eda y Salud P\u00fablica, Universidad Libre, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3810-4943","authenticated-orcid":false,"given":"Jos\u00e9 F.","family":"Fuertes-Bucheli","sequence":"additional","affiliation":[{"name":"Semillero de Investigaci\u00f3n de Microbiolog\u00eda y Salud P\u00fablica, Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"},{"name":"Semillero de Investigaci\u00f3n de Microbiolog\u00eda y Salud P\u00fablica, Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2525-9935","authenticated-orcid":false,"given":"Robinson","family":"Pacheco","sequence":"additional","affiliation":[{"name":"Grupo Interdisciplinario de Investigaci\u00f3n en Epidemiolog\u00eda y Salud P\u00fablica, Universidad Libre, Cali, Colombia"},{"name":"Grupo Interdisciplinario de Investigaci\u00f3n en Epidemiolog\u00eda y Salud P\u00fablica, Universidad Libre, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2023,9,30]]},"reference":[{"key":"125739","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez L, Shen Y, Mupere E, Kizza A, Hill PC, Whalen CC. Transmission of Mycobacterium tuberculosis in households and the community: A systematic review and meta-analysis. Am J Epidemiol. 2017;185:1327-39. https:\/\/doi.org\/10.1093\/aje\/kwx025","DOI":"10.1093\/aje\/kwx025"},{"key":"125740","unstructured":"World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Fecha de consulta: 26 de marzo de 2023. Disponible en: https:\/\/apps.who.int\/iris\/handle\/10665\/346387"},{"key":"125741","unstructured":"World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization; 2022. Fecha de consulta: 6 de junio de 2023. Disponible en: https:\/\/apps.who.int\/iris\/handle\/10665\/363752"},{"key":"125742","doi-asserted-by":"crossref","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe. 2023;4:e20. https:\/\/doi.org\/10.1016\/S2666-5247(22)00359-7","DOI":"10.1016\/S2666-5247(22)00359-7"},{"key":"125743","doi-asserted-by":"crossref","unstructured":"Instituto Nacional de Salud. Protocolo de Vigilancia en Salud P\u00fablica de Tuberculosis. Versi\u00f3n 6, 2022. Fecha de consulta: 6 de junio de 2023. Disponible en: https:\/\/doi.org\/10.33610\/infoeventos","DOI":"10.33610\/400816ruxhbr"},{"key":"125744","unstructured":"Ministerio de Salud de Colombia. Resoluci\u00f3n 227 de 2020. Lineamientos t\u00e9cnicos y operativos del programa nacional de tuberculosis. 2020. Fecha de consulta: 9 de diciembre de 2022. Disponible en: https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/DE\/DIJ\/resolucion-227-de-2020.pdf"},{"key":"125745","doi-asserted-by":"crossref","unstructured":"Bernal O, L\u00f3pez R, Montoro E, Avedillo P, Westby K, Ghidinelli M. Determinantes sociales y meta de tuberculosis en los Objetivos de Desarrollo Sostenible en las Am\u00e9ricas. Rev Panam Salud Publica. 2020;44:1. https:\/\/doi.org\/10.26633\/rpsp.2020.153","DOI":"10.26633\/RPSP.2020.153"},{"key":"125746","doi-asserted-by":"crossref","unstructured":"Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar J-W. Risk factors of multidrugresistant tuberculosis: A global systematic review and meta-analysis. J Infect. 2018;77:469-78. https:\/\/doi.org\/10.1016\/j.jinf.2018.10.004","DOI":"10.1016\/j.jinf.2018.10.004"},{"key":"125747","doi-asserted-by":"crossref","unstructured":"Li S, Liang Y, Hu X. Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus. BMC Infect Dis. 2022;22:835. https:\/\/doi.org\/10.1186\/s12879-022-07831-3","DOI":"10.1186\/s12879-022-07831-3"},{"key":"125748","doi-asserted-by":"crossref","unstructured":"Pan Y, Yu Y, Lu J, Yi Y, Dou X, Zhou L. Drug resistance patterns and trends in patients with suspected drug-resistant tuberculosis in Dalian, China: A retrospective study. Infect Drug Resist. 2022;15:4137-47. https:\/\/doi.org\/10.2147\/IDR.S373125","DOI":"10.2147\/IDR.S373125"},{"key":"125749","doi-asserted-by":"crossref","unstructured":"Xing W, Zhang R, Jiang W, Zhang T, Pender M, Zhou J, et al. Adherence to multidrug resistant tuberculosis treatment and case management in Chongqing, China - A mixed method research study. Infect Drug Resist. 2021;14:999-1012. https:\/\/doi.org\/10.2147\/IDR.S293583","DOI":"10.2147\/IDR.S293583"},{"key":"125750","doi-asserted-by":"crossref","unstructured":"Chen X, Du L, Wu R, Xu J, Ji H, Zhang Y, et al. The effects of family, society and national policy support on treatment adherence among newly diagnosed tuberculosis patients: a cross-sectional study. BMC Infect Dis. 2020;20:623. https:\/\/doi.org\/10.1186\/s12879-020-05354-3","DOI":"10.1186\/s12879-020-05354-3"},{"key":"125751","doi-asserted-by":"crossref","unstructured":"Du L, Chen X, Zhu X, Zhang Y, Wu R, Xu J, et al. Determinants of medication adherence for pulmonary tuberculosis patients during continuation phase in Dalian, northeast China. Patient Prefer Adherence. 2020;14:1119-28. https:\/\/doi.org\/10.2147\/PPA.S243734","DOI":"10.2147\/PPA.S243734"},{"key":"125752","unstructured":"Saavedra-Romero J, Zorayda-Clara AN. Factores asociados a la no adherencia al tratamiento en pacientes con tuberculosis sensible en el Centro de Salud San Cosme, Lima 2018. Lima: Universidad Mar\u00eda Auxiliadora; 2019. Fecha de consulta: 9 de diciembre de 2022. https:\/\/repositorio.uma.edu.pe\/handle\/20.500.12970\/176"},{"key":"125753","doi-asserted-by":"crossref","unstructured":"Paniagua-Saldarriaga LA, Pelissari DM, Rueda ZV. Factors associated with unsuccessful outcomes of tuberculosis treatment in 125 municipalities in Colombia 2014 to 2016. Am J Trop Med Hyg. 2021;105:1326-34. https:\/\/doi.org\/10.4269\/ajtmh.20-1063","DOI":"10.4269\/ajtmh.20-1063"},{"key":"125754","doi-asserted-by":"crossref","unstructured":"Chaves-Torres NM, Fadul S, Pati\u00f1o J, Netto E. Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study. PLoS One. 2021;16:e0249565. https:\/\/doi.org\/10.1371\/journal.pone.0249565","DOI":"10.1371\/journal.pone.0249565"},{"key":"125755","doi-asserted-by":"crossref","unstructured":"Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med. 2008;149:123-34. https:\/\/doi.org\/10.7326\/0003-4819-149-2-200807150-00008","DOI":"10.7326\/0003-4819-149-2-200807150-00008"},{"key":"125756","doi-asserted-by":"crossref","unstructured":"Teferi MY, El-Khatib Z, Boltena MT, Andualem AT, Asamoah BO, Biru M, et al. Tuberculosis treatment outcome and predictors in Africa: A systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18:10678. https:\/\/doi.org\/10.3390\/ijerph182010678","DOI":"10.3390\/ijerph182010678"},{"key":"125757","unstructured":"Ministerio de Salud de Colombia. Informe de evento tuberculosis a\u00f1o 2021. Fecha de consulta: 9 de diciembre de 2022. Disponible en: https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/VS\/PP\/ET\/comportamiento-tuberculosis-2020.pdf"},{"key":"125758","doi-asserted-by":"crossref","unstructured":"Wrohan I, Nguyen TA, Nguyen VN, Nguyen BH, Hoang TTT, Nguyen PC, et al. Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort study. BMC Infect Dis. 2022;22:68. https:\/\/doi.org\/10.1186\/s12879-021-06992-x","DOI":"10.1186\/s12879-021-06992-x"},{"key":"125759","doi-asserted-by":"crossref","unstructured":"Singano V, Kip E, Ching\u2019ani W, Chiwaula L. Tuberculosis treatment outcomes among prisoners and general population in Zomba, Malawi. BMC Public Health. 2020;20:700. https:\/\/doi.org\/10.1186\/s12889-020-08841-z","DOI":"10.1186\/s12889-020-08841-z"},{"key":"125760","unstructured":"Organizaci\u00f3n Mundial de la Salud. Definiciones y marco de trabajo para la notificaci\u00f3n de tuberculosis - revisi\u00f3n 2013. Organizaci\u00f3n Mundial de la Salud; 2013. Fecha de consulta: 9 de diciembre de 2022. Disponible en: https:\/\/apps.who.int\/iris\/handle\/10665\/111016"},{"key":"125761","doi-asserted-by":"crossref","unstructured":"Organizaci\u00f3n Panamericana de Salud. Manual operativo de la OMS sobre la tuberculosis. M\u00f3dulo 4: tratamiento. Tratamiento de la tuberculosis farmacorresistente. Washington D. C.: Pan American Health Organization; 2022. https:\/\/doi.org\/10.37774\/9789275325575","DOI":"10.37774\/9789275325575"},{"key":"125762","unstructured":"Alcald\u00eda de Santiago de Cali, Documentos de Cali en cifras. Fecha de consulta: 26 de marzo de 2023. Disponible en: https:\/\/www.cali.gov.co\/planeacion\/publicaciones\/137803\/documentos-cali-en-cifras\/"},{"key":"125763","doi-asserted-by":"crossref","unstructured":"Silva C, Barroso M. Selecci\u00f3n algor\u00edtmica de modelos en las aplicaciones biom\u00e9dicas de la regresi\u00f3n m\u00faltiple. Med Clin (Barc). 2001;116:741-5. https:\/\/doi.org\/10.1016\/S0025-7753(01)71971-9","DOI":"10.1016\/S0025-7753(01)71971-9"},{"key":"125764","doi-asserted-by":"crossref","unstructured":"Hosmer D, Lemeshow S, Sturdivant RX. Applied Logistic Regression: Hosmer\/applied logistic regression. 3a ed. Hoboken, NJ, United States: Wiley-Blackwell; 2013. https:\/\/doi.org\/10.1002\/9781118548387","DOI":"10.1002\/9781118548387"},{"key":"125765","unstructured":"Ministerio de Salud de Per\u00fa. Bolet\u00edn de tuberculosis. 2022:01. Fecha de consulta: 9 de diciembre de 2022. Disponible en: https:\/\/cdn.www.gob.pe\/uploads\/document\/file\/3514064\/Boletin%20tuberculosis%2001%20agosto%20-%202022%20%281%29.pdf"},{"key":"125766","doi-asserted-by":"crossref","unstructured":"Organizaci\u00f3n Panamericana de Salud. Tuberculosis en las Am\u00e9ricas. Informe regional 2020. Washington D. C.: Organizaci\u00f3n Panamericana de Salud; 2021. https:\/\/doi.org\/10.37774\/9789275324479","DOI":"10.37774\/9789275324479"},{"key":"125767","doi-asserted-by":"crossref","unstructured":"Herrero MB, Arrossi S, Ramos S, Braga JU. Spatial analysis of the tuberculosis treatment dropout, Buenos Aires, Argentina. Rev Saude Publica. 2015;49:49. https:\/\/doi.org\/10.1590\/S0034-8910.2015049005391","DOI":"10.1590\/S0034-8910.2015049005391"},{"key":"125768","doi-asserted-by":"crossref","unstructured":"Machado-Alba JE, Cantor AM, Montes A, Augusto-Quintero C. Efectividad del tratamiento antituberculoso en tres ciudades de Colombia. Infectio. 2013;17:73-9. https:\/\/doi.org\/10.1016\/s0123-9392(13)70166-8","DOI":"10.1016\/S0123-9392(13)70166-8"},{"key":"125769","doi-asserted-by":"crossref","unstructured":"Macedo LR, Maciel ELN, Struchiner CJ. Popula\u00e7\u00f5es vulner\u00e1veis e o desfecho dos casos de tuberculose no Brasil. Cien Saude Colet. 2021;26:4749-59. https:\/\/doi.org\/10.1590\/1413-812320212610.24132020","DOI":"10.1590\/1413-812320212610.24132020"},{"key":"125770","doi-asserted-by":"crossref","unstructured":"Santosa ACE, Brunfentrinkera C, Penaa LS, Saraivaa SS, Boinga AF. Analysis and comparison of tuberculosis treatment outcomes in the homeless population and in the general population of Brazil. J Bras Pneumol. 2021;47:e20200178. https:\/\/doi.org\/10.36416\/1806-3756\/e20200178","DOI":"10.36416\/1806-3756\/e20200178"},{"key":"125771","doi-asserted-by":"crossref","unstructured":"Silva D, Mu\u00f1oz-Torrico M, Duarte R, Galv\u00e3o T, Bonini E, Arbex F, et al. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol. 2018;44:145-52. https:\/\/doi.org\/10.1590\/s1806-37562017000000443","DOI":"10.1590\/s1806-37562017000000443"},{"key":"125772","doi-asserted-by":"crossref","unstructured":"Sem\u00e1 Baltazar C, Kellogg TA, Boothe M, Loarec A, de Abreu E, Condula M, et al. Prevalence of HIV, viral hepatitis B\/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique. Int J Drug Policy. 2021;90:103095. https:\/\/doi.org\/10.1016\/j.drugpo.2020.103095","DOI":"10.1016\/j.drugpo.2020.103095"},{"key":"125773","doi-asserted-by":"crossref","unstructured":"Soares M, Amaral N, Zacarias A, Ribeiro L. Aspectos sociodemogr\u00e1ficos e cl\u00ednicoepidemiol\u00f3gicos do abandono do tratamento de tuberculose em Pernambuco, Brasil, 2001-2014. Epidemiol Serv Saude. 2017;26:369-78. https:\/\/doi.org\/10.5123\/s1679-49742017000200014","DOI":"10.5123\/S1679-49742017000200014"},{"key":"125774","doi-asserted-by":"crossref","unstructured":"Izudi J, Tamwesigire IK, Bajunirwe F. Treatment success and mortality among adults with tuberculosis in rural eastern Uganda: a retrospective cohort study. BMC Public Health. 2020;20:501. https:\/\/doi.org\/10.1186\/s12889-020-08646-0","DOI":"10.1186\/s12889-020-08646-0"},{"key":"125775","doi-asserted-by":"crossref","unstructured":"Sahakyan S, Petrosyan V, Abrahamyan L. Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: a cohort study. Int J Public Health. 2020;65:37-43. https:\/\/doi.org\/10.1007\/s00038-019-01277-2","DOI":"10.1007\/s00038-019-01277-2"},{"key":"125776","doi-asserted-by":"crossref","unstructured":"Zenebe Y, Adem Y, Mekonnen D, Derbie A, Bereded F, Bantie M, et al. Profile of tuberculosis and its response to anti-tuberculosis drugs among tuberculosis patients treated under the Tuberculosis Control Programme at Felege-Hiwot Referral Hospital, Ethiopia. BMC Public Health. 2016;16. https:\/\/doi.org\/10.1186\/s12889-016-3362-9","DOI":"10.1186\/s12889-016-3362-9"},{"key":"125777","doi-asserted-by":"crossref","unstructured":"Koo H-K, Min J, Kim HW, Lee J, Kim JS, Park JS, et al. Prediction of treatment failure and compliance in patients with tuberculosis. BMC Infect Dis. 2020;20:622. https:\/\/doi.org\/10.1186\/s12879-020-05350-7","DOI":"10.1186\/s12879-020-05350-7"},{"key":"125778","doi-asserted-by":"crossref","unstructured":"Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, et al. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and metaanalysis of trials and observational studies. PLoS Med. 2018;15:e1002595. https:\/\/doi.org\/10.1371\/journal.pmed.1002595","DOI":"10.1371\/journal.pmed.1002595"},{"key":"125779","doi-asserted-by":"crossref","unstructured":"Fuertes-Bucheli JF, Fuertes-Bucheli KA. Para una participaci\u00f3n pol\u00edtica ciudadana saludable es necesario gestionar la infodemia. Revista Lecciones Vitales. 2023;lv0102. https:\/\/doi.org\/10.18046\/rlv.2023.5595","DOI":"10.18046\/rlv.2023.5595"},{"key":"125780","doi-asserted-by":"crossref","unstructured":"Strba Idarraga LC, Alarcon Soto J, Figueroa Gomez JE, Ahumada Figueroa KT, Ni\u00f1o Y, Pacheco Lopez R. Conocimientos, percepciones de riesgo y estigma sobre tuberculosis en poblaci\u00f3n carcelaria de Cali, Colombia, 2020. Revista de Investigaci\u00f3n UPNW. 2021;10:119-37. https:\/\/doi.org\/10.37768\/unw.rinv.10.02.010","DOI":"10.37768\/unw.rinv.10.02.010"},{"key":"125781","doi-asserted-by":"crossref","unstructured":"Fuertes-Bucheli JF, Pel\u00e1ez-Mart\u00ednez JD, Mart\u00ednez-Ni\u00f1o M del M, Aguilar-Gonzalez AM, Dorris M, Ferro BE, et al. Quinta arremetida de COVID-19 y el uso de mascarillas en espacios abiertos y cerrados. Revista Universidad y Salud. 2022;24:267-72. https:\/\/doi.org\/10.22267\/rus.222403.281","DOI":"10.22267\/rus.222403.281"},{"key":"125782","doi-asserted-by":"crossref","unstructured":"Becker C, Zumbrunn S, Beck K, Vincent A, Loretz N, M\u00fcller J, et al. Interventions to improve communication at hospital discharge and rates of readmission: A systematic review and meta-analysis: A systematic review and meta-analysis. JAMA Netw Open. 2021;4:e2119346. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.19346","DOI":"10.1001\/jamanetworkopen.2021.19346"},{"key":"125783","doi-asserted-by":"crossref","unstructured":"Zago PTN, Maffacciolli R, Riquinho DL, Kruse MHL, Rocha CMF. Treatment adherence under the foucauldian perspective: knowledge\/powers in tuberculosis control manuals in Brazil. Rev Gaucha Enferm. 2022;43:e20210075. https:\/\/doi.org\/10.1590\/1983-1447.2022.20210075.en","DOI":"10.1590\/1983-1447.2022.20210075.pt"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6961\/5289","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6961\/5389","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6961\/5289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:14:34Z","timestamp":1773328474000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/6961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9,30]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.6961","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,30]]},"assertion":[{"value":"2023-09-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Original articles","name":"content_type","label":"Content Type"}]}}